Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection

Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection

Bibliographic Details
Main Authors:	Boghuma Titanji, Christina Gavegnano, Priscilla Hsue, Raymond Schinazi, Vincent C. Marconi
Format:	Article
Language:	English
Published:	Wiley 2020-02-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	atherosclerosis HIV infection inflammation prevention
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.119.014873

Similar Items

Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia
by: D.C. Boettiger, et al.
Published: (2020-01-01)

Atherosclerotic vascular disorders in HIV infected patients
by: John Palios, et al.
Published: (2011-07-01)

Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV
by: Christina Gavegnano, et al.
Published: (2019-10-01)

Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV
by: Léna Royston, et al.
Published: (2022-08-01)

Host SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophages
by: Bijan Mahboubi, et al.
Published: (2018-10-01)

Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives
by: Paraskevi C. Fragkou, et al.
Published: (2023-05-01)

Sub-clinical atherosclerosis in HIV-infected patients: prevalence and risk factors
by: Meriam Abdeljelil, et al.
Published: (2023-11-01)

Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study
by: Sirawat Srichatrapimuk, et al.
Published: (2023-02-01)

Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet Aggregation
by: Sofija I. Lugonja, et al.
Published: (2023-03-01)

Markers of subclinical atherosclerotic disease in HIV-infected individuals
by: Pulin K. Gupta, et al.
Published: (2018-01-01)

Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections
by: Monica D. Reece, et al.
Published: (2022-12-01)

Extending HIV Prevention: People Living With HIV/AIDS (PLWHA) Strategize to Reduce Stigma and Promote HIV Testing
by: Tiffiany Cummings Aholou, et al.
Published: (2009-10-01)

Vaxxing to elimination: smallpox vaccines as tools to fight mpox
by: Boghuma K. Titanji, et al.
Published: (2023-01-01)

Case Report: Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc)
by: Dominik M. Schulte, et al.
Published: (2022-06-01)

HIV‐Associated Cardiovascular Disease: Beyond the Macrovascular
by: Ashley B. Pournamdari, et al.
Published: (2023-11-01)

HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan
by: Matthew S. Freiberg, et al.
Published: (2016-03-01)

Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients
by: Teresa Strisciuglio, et al.
Published: (2020-07-01)

Atherosclerosis in HIV Patients: What Do We Know so Far?
by: Anastasia V. Poznyak, et al.
Published: (2022-02-01)

Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan
by: Shu-ting Chen, et al.
Published: (2019-03-01)

Reducing cardiovascular risk: an emphasis on rosuvastatin
by: Anikin G.S., et al.
Published: (2017-11-01)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
by: Harald Mangge, et al.
Published: (2019-08-01)

Risk factors and assessment for cardiovascular disease among HIV-positive patients attending a Nigerian tertiary hospital
by: Ifeyinwa Dorothy Osegbe, et al.
Published: (2016-04-01)

Role of Omega-3 Fatty Acids in Dyslipidemia and Cardiovascular Diseases
by: Grace Fonda, et al.
Published: (2017-04-01)

Genome-wide associated variants of subclinical atherosclerosis among young people with HIV and gene-environment interactions
by: Jiayu He, et al.
Published: (2022-12-01)

The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency
by: Lesley R. de Armas, et al.
Published: (2021-08-01)

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
by: Michael J. Wilkinson, et al.
Published: (2023-06-01)

Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro
by: Christina Gavegnano, et al.
Published: (2019-09-01)

Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation
by: Hongxia Li, et al.
Published: (2022-03-01)

Novel Biomarkers for Atherosclerotic Disease: Advances in Cardiovascular Risk Assessment
by: Raul-Alexandru Jigoranu, et al.
Published: (2023-07-01)

Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies
by: Stanisław Surma, et al.
Published: (2021-12-01)

Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression
by: Max Lenz, et al.
Published: (2021-01-01)

Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV
by: Arjun Sinha, et al.
Published: (2016-12-01)

An overview of some of the novel research in the field of atherosclerosis (According to the materials of the reports presented at the 81st Congress of the European Atherosclerotic Society (EAS) June 2–5, 2013, Lyon, France)
by: D. V. Denisova
Published: (2013-06-01)

Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort
by: Jae Hyun Bae, et al.
Published: (2020-06-01)

Trained Immunity as a Trigger for Atherosclerotic Cardiovascular Disease—A Literature Review
by: Natalia Anna Zieleniewska, et al.
Published: (2022-06-01)

The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment
by: Karl Goodkin, et al.
Published: (2023-04-01)

Lymphomas in People Living with HIV
by: Emanuela Vaccher, et al.
Published: (2022-09-01)

Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: Team-Based Learning
by: Asma Arabi, et al.
Published: (2015-09-01)

Grayscale Ultrasound Texture Features of Carotid and Brachial Arteries in People With HIV Infection Before and After Antiretroviral Therapy
by: Christina M. Hughey, et al.
Published: (2022-03-01)

Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
by: Taylor Fleming, et al.
Published: (2020-07-01)